Influenza infection and heart failure—vaccination may change heart failure prognosis?

Heart Failure Reviews

Volumn 22, Issue 3, 2017, Pages 329-336

  Kadoglou, Nikolaos P E ^a,b   Bracke, Frank ^a   Simmers, Tim ^a   Tsiodras, Sotirios ^c   Parissis, John ^c  

^a CATHARINA HOSPITAL   (Netherlands)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Decompensation; Dose; Heart failure; Hospitalization; Immunization; Influenza infection; Mortality; Vaccination

Indexed keywords

INFLUENZA VACCINE;

ACUTE HEART FAILURE; CAUSE OF DEATH; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; HEART FAILURE; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; MORBIDITY; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; PATHOGENESIS; PATIENT ADVOCACY; PRACTICE GUIDELINE; PROGNOSIS; PUBLIC HEALTH PROBLEM; REVIEW; SECONDARY PREVENTION; WORLD HEALTH ORGANIZATION; ACUTE DISEASE; COMPLICATION; GLOBAL HEALTH; INCIDENCE; INFLUENZA A VIRUS; PROCEDURES; RISK FACTOR; VACCINATION;

ACUTE DISEASE; GLOBAL HEALTH; HEART FAILURE; HUMANS; INCIDENCE; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PROGNOSIS; RISK FACTORS; VACCINATION;

EID: 85019240412     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-017-9614-7     Document Type: Review

References (57)

1. Ryu SW, Lee JH, Kim J, Jang MA, Nam JH, Byoun MS, Lim CS (2016) Comparison of two new generation influenza rapid diagnostic tests with instrument-based digital readout systems for influenza virus detection. Br J Biomed Sci 21:1–6
2. Breen M, Nogales A, Baker SF, Perez DR, Martínez-Sobrido L (2016) Replication-competent influenza A and B viruses expressing a fluorescent dynamic timer protein for in vitro and in vivo studies. PLoS One 1:e0147723
3. Oshansky CM, Wong SS, Jeevan T, Smallwood HS, Webby RJ, Shafir SC, Thomas PG (2014) Seasonal influenza vaccination is the strongest correlate of cross-reactive antibody responses in migratory bird handlers. MBio 5:e02107
4. World Health Organization (2014) Fact sheet on influenza. http://www.who.int/mediacentre/factsheets/fs211/en/
5. Brendish NJ, Schiff HF, Clark TW (2015) Point-of-care testing for respiratory viruses in adults: the current landscape and future potential. J Inf Secur 71:501–510
6. Nguyen JL, Yang W, Ito K, Matte TD, Shaman J, Kinney PL (2016) Seasonal influenza infections and cardiovascular disease mortality. JAMA Cardiol 1:274–281
7. Nicholson KG (1998) Human influenza. In: Nicholson KG, Webster RG, Hay AJ (eds) Textbook of influenza. Blackwell Science, Oxford, pp 219–264
8. Bramley AM, Dasgupta S, Skarbinski J, Kamimoto L, Fry AM, Finelli L, Jain S (2012) Pandemic influenza A (H1N1) virus hospitalizations investigation team. Intensive care unit patients with 2009 pandemic influenza A (H1N1pdm09) virus infection—United States, 2009. Influenza Other Respir Viruses 6:e134–e142
9. Smith AM (2017) Quantifying the therapeutic requirements and potential for combination therapy to prevent bacterial coinfection during influenza. J Pharmacokinet Pharmacodyn 44:81–93
10. Cromer D, van Hoek AJ, Jit M, Edmunds WJ, Fleming D, Miller E (2014) The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy. J Inf Secur 68:363–371
11. Corrales-Medina VF, Alvarez KN, Weissfeld LA, Angus DC, Chirinos JA, Chang CC, Newman A, Loehr L, Folsom AR, Elkind MS, Lyles MF, Kronmal RA, Yende S (2015) Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA 313:264–274
12. Warren-Gash C, Smeeth L, Hayward AC (2009) Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis 9:601–610
13. Barnes M, Heywood AE, Mahimbo A, Rahman B, Newall AT, Macintyre CR (2015) Acute myocardial infarction and influenza: a meta-analysis of case-control studies. Heart 101:1738–1747
14. Dick SA, Epelman S (2016) Chronic heart failure and inflammation: what do we really know? Circ Res 119:159–176
15. Fagnoul D, Pasquier P, Bodson L, Ortiz JA, Vincent JL, De Backer D (2013) Myocardial dysfunction during H1N1 influenza infection. J Crit Care 28:321–327
16. Ludwig A, Lucero-Obusan C, Schirmer P, Winston C, Holodniy M (2015) Acute cardiac injury events ≤30 days after laboratory-confirmed influenza virus infection among U.S. veterans, 2010–2012. BMC Cardiovasc Disord. 15:109.
17. Marti CN, Georgiopoulou VV, Kalogeropoulos AP (2013) Acute heart failure: patient characteristics and pathophysiology. Curr Heart Fail Rep. 10:427–433
18. Tomiyama H, Yamashina A (2015) Vascular dysfunction: a key player in chronic cardio-renal syndrome. Intern Med 54:1465–1472
19. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Authors/Task Force Members; Document Reviewers (2016) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18:891–975
20. Patel NJ, Nalluri N, Deshmukh A, Pant S, Shah N, Badheka AO, Asti D, Lafferty JC, Schwartz C (2014) Seasonal trends of heart failure hospitalizations in the United States: a national perspective from 2000 to 2011. Int J Cardiol 173:562–563
21. Sandoval C, Walter SD, Krueger P, Smieja M, Smith A, Yusuf S, Loeb MB (2007) Risk of hospitalization during influenza season among a cohort of patients with congestive heart failure. Epidemiol Infect 135:574–582
22. Xu B, Liu H, Su N, Kong G, Bao X, Li J, Wang J, Li Y, Ma X, Zhang J, Yu GP, Zhao L (2013) Association between winter season and risk of death from cardiovascular diseases: a study in more than half a million inpatients in Beijing. China BMC Cardiovasc Disord 13:93
23. Godoy HL, Silveira JA, Segalla E, Almeida DR (2011) Hospitalization and mortality rates for heart failure in public hospitals in São Paulo. Arq Bras Cardiol 97:402–407
24. Colombo PC, Ganda A, Lin J, Onat D, Harxhi A, Iyasere JE, Uriel N, Cotter G (2012) Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardio-renal syndrome. Heart Fail Rev 17:177–190
25. Colombo PC, Doran AC, Onat D, Wong KY, Ahmad M, Sabbah HN, Demmer RT (2015) Venous congestion, endothelial and neurohormonal activation in acute decompensated heart failure: cause or effect? Curr Heart Fail Rep. 12:215–222
26. Ganda A, Onat D, Demmer RT, Wan E, Vittorio TJ, Sabbah HN, Colombo PC (2010) Venous congestion and endothelial cell activation in acute decompensated heart failure. Curr Heart Fail Rep 7:66–74
27. Chang DH, Bednarczyk RA, Becker ER, Hockenberry JM, Weiss PS, Orenstein WA, Omer SB (2016) Trends in U.S. hospitalizations and inpatient deaths from pneumonia and influenza, 1996–2011. Vaccine 34:486–494
28. Wang CS, Wang ST, Lai CT, Lin LJ, Lee CT, Chou P (2004) Reducing major cause-specific hospitalization rates and shortening hospital stays after influenza vaccination. Clin Infect Dis 39:1604–1610
29. Ridenhour BJ, Campitelli MA, Kwong JC, Rosella LC, Armstrong BG, Mangtani P, Calzavara AJ, Shay DK (2013) Effectiveness of inactivated influenza vaccines in preventing influenza-associated deaths and hospitalizations among Ontario residents aged ≥65 years: estimates with generalized linear models accounting for healthy vaccinee effects. PLoS One 8:e76318
30. Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E (2007) Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 357:1373–1381
31. de Diego C, Vila-Córcoles A, Ochoa O, Rodriguez-Blanco T, Salsench E, Hospital I, Bejarano F, Del Puy Muniain M, Fortin M, Canals M, EPIVAC Study Group (2009) Effects of annual influenza vaccination on winter mortality in elderly people with chronic heart disease. Eur Heart J 30:209–216
32. Gwini SM, Coupland CA, Siriwardena AN (2011) The effect of influenza vaccination on risk of acute myocardial infarction: self-controlled case-series study. Vaccine 29:1145–1149
33. Macintyre CR, Heywood AE, Kovoor P, Ridda I, Seale H, Tan T, Gao Z, Katelaris AL, Siu HW, Lo V, Lindley R, Dwyer DE (2013) Ischaemic heart disease, influenza and influenza vaccination: a prospective case control study. Heart 99:1843–1848
34. Heffelfinger JD, Heckbert SR, Psaty BM, Weiss NS, Thompson WW, Bridges CB, Jackson LA (2006) Influenza vaccination and risk of incident myocardial infarction. Hum Vaccin. 2:161–166
35. Clar C, Oseni Z, Flowers N, Keshtkar-Jahromi M, Rees K (2015) Influenza vaccines for preventing cardiovascular disease. Cochrane Database Syst Rev 5:CD005050
36. Baxter R, Ray GT, Fireman BH (2010) Effect of influenza vaccination on hospitalizations in persons aged 50 years and older. Vaccine 28:7267–7272
37. Arriola CS, Anderson EJ, Baumbach J, Bennett N, Bohm S, Hill M, Lindegren ML, Lung K, Meek J, Mermel E, Miller L, Monroe ML, Morin C, Oni O, Reingold A, Schaffner W, Thomas A, Zansky SM, Finelli L, Chaves SS (2015) Does influenza vaccination modify influenza severity? Data on older adults hospitalized with influenza during the 2012–2013 season in the United States. J Infect Dis 212:1200–1208
38. Davis MM, Taubert K, Benin AL, Brown DW, Mensah GA, Baddour LM, Dunbar S, Krumholz HM, American Heart Association, American College of Cardiology, American Association of Cardiovascular and Pulmonary Rehabilitation, American Association of Critical Care Nurses, American Association of Heart Failure Nurses, American Diabetes Association, Association of Black Cardiologists, Inc, Heart Failure Society of America, Preventive Cardiovascular Nurses Association, American Academy of Nurse Practitioners, Centers for Disease Control and Prevention and the Advisory Committee on Immunization (2006) Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. J Am Coll Cardiol 48:1498–1502
39. Members TF, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabaté M, Senior R, Taggart DP, van der Wall EE, Vrints CJ, ESC Committee for Practice Guidelines, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Reviewers D, Knuuti J, Valgimigli M, Bueno H, Claeys MJ, Donner-Banzhoff N, Erol C, Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Hasdai D, Husted S, James SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, Maggioni AP, Piepoli MF, Pries AR, Romeo F, Rydén L, Simoons ML, Sirnes PA, Steg PG, Timmis A, Wijns W, Windecker S, Yildirir A, Zamorano JL (2013) ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34:2949–3003
40. Vamos EP, Pape UJ, Curcin V, Harris MJ, Valabhji J, Majeed A, Millett C (2016) Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes. CMAJ 188:E342–E351
41. Liu IF, Huang CC, Chan WL, Huang PH, Chung CM, Lin SJ, Chen JW, Leu HB (2012) Effects of annual influenza vaccination on mortality and hospitalization in elderly patients with ischemic heart disease: a nationwide population-based study. Prev Med 54:431–433
42. Mohseni H, Kiran A, Khorshidi R, Rahimi K (2017) Influenza vaccination and risk of hospitalization in patients with heart failure: a self-controlled case series study. Eur Heart J 38:326–333
43. Kopel E, Klempfner R, Goldenberg I (2014) Influenza vaccine and survival in acute heart failure. Eur J Heart Fail 16:264–270
44. Vardeny O, Claggett B, Udell JA, Packer M, Zile M, Rouleau J, Swedberg K, Desai AS, Lefkowitz M, Shi V, McMurray JJ, Solomon SD, Investigators PARADIGM-HF (2016) Influenza vaccination in patients with chronic heart failure: the PARADIGM-HF trial. JACC Heart Fail. 4:152–158
45. Wu WC, Jiang L, Friedmann PD, Trivedi A (2014) Association between process quality measures for heart failure and mortality among US veterans. Am Heart J 168:713–720
46. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M (2003) Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 348:1322–1332
47. Fang YA, Chen CI, Liu JC, Sung LC (2016) Influenza vaccination reduces hospitalization for heart failure in elderly patients with chronic kidney disease: a population-based cohort study. Acta Cardiol Sin 32:290–298
48. Acharya D, Uyeki TM (2016) The PARADIGM of influenza vaccination in heart failure patients. JACC Heart Fail 4:159–161
49. Liu WM, van der Zeijst BA, Boog CJ, Soethout EC (2011) Aging and impaired immunity to influenza viruses: implications for vaccine development. Hum Vaccin 7(Suppl):94–98
50. Vardeny O, Sweitzer NK, Detry MA, Moran JM, Johnson MR, Hayney MS (2009) Decreased immune responses to influenza vaccination in patients with heart failure. J Card Fail 15:368–373
51. Vardeny O, Moran JJ, Sweitzer NK, Johnson MR, Hayney MS (2010) Decreased T-cell responses to influenza vaccination in patients with heart failure. Pharmacotherapy 30:10–16
52. Albrecht CM, Sweitzer NK, Johnson MR, Vardeny O (2014) Lack of persistence of influenza vaccine antibody titers in patients with heart failure. J Card Fail 20:105–109
53. DiazGranados CA, Dunning AJ, Kimmel M, Kirby D, Treanor J, Collins A, Pollak R, Christoff J, Earl J, Landolfi V, Martin E, Gurunathan S, Nathan R, Greenberg DP, Tornieporth NG, Decker MD, Talbot HK (2014) Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med 371:635–645
54. Van Ermen A, Hermanson MP, Moran JM, Sweitzer NK, Johnson MR, Vardeny O (2013) Double dose vs. standard dose influenza vaccination in patients with heart failure: a pilot study. Eur J Heart Fail 15:560–564
55. Yao X, Hamilton RG, Weng NP, Xue QL, Bream JH, Li H, Tian J, Yeh SH, Resnick B, Xu X, Walston J, Fried LP, Leng SX (2011) Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults. Vaccine 29:5015–5021
56. Black S, Eskola J, Siegrist CA, Halsey N, Macdonald N, Law B, Miller E, Andrews N, Stowe J, Salmon D, Vannice K, Izurieta HS, Akhtar A, Gold M, Oselka G, Zuber P, Pfeifer D, Vellozzi C (2009) Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet 374:2115–2122
57. Kawai AT, Li L, Kulldorff M, Vellozzi C, Weintraub E, Baxter R, Belongia EA, Daley MF, Jacobsen SJ, Naleway A, Nordin JD, Lee GM (2014) Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012–2013 season. Pharmacoepidemiol Drug Saf 23:548–553